The Condition
Severe depressive states are neuropsychiatric disorders characterized by persistent low mood, anhedonia, cognitive impairment, and neurovegetative symptoms, associated with monoamine deficits, hypothalamic-pituitary-adrenal axis dysregulation, and neuroinflammation.
How the Plant Resolves It
While psychiatric care remains primary, central-acting volatile terpenes, monoamine oxidase modulators, and receptor agents provide biochemical support by easing central nervous system excitotoxicity, mitigating oxidative stress, and restoring stability to neural signaling networks.
- 1.Volatile terpenes and MAO modulators ease CNS excitotoxicity.
- 2.Oxidative stress in neural tissue is mitigated.
- 3.Stability is restored to signaling networks (alongside professional care).
How Each Specimen Contributes
Mimosa / Persian Silk Tree
Julibrin saponins modulate serotonergic and noradrenergic signaling in the limbic system, providing adaptogenic mood support alongside psychiatric care.
Magnolia
Magnolol and honokiol act as GABA-A receptor positive allosteric modulators, restoring inhibitory tone and reducing the anxiety and insomnia that accompany severe depression.
Sweet Gum
Cinnamic acid derivatives inhibit monoamine oxidase-A, increasing synaptic serotonin and norepinephrine availability in the prefrontal cortex.
Bald Cypress
Taxodione triterpenoids suppress microglial neuroinflammation, reducing the IL-6 and TNF-α output that correlates with depressive symptom severity.
Pine
Pinocembrin and chrysin mitigate oxidative stress in the hippocampus, protecting the neural stem cells that support neurogenesis and mood regulation.
Natural calming compounds soothe overactive brain signals and lower cellular stress to help restore nervous system balance alongside professional care.
Plants & Trees that treat it
Click any specimen to open its pharmacognostic monograph.
Academic Citations
- 1.Al Mamun A, Shao C, Geng P, Wang S, Xiao J. Polyphenols targeting NF-κB pathway in neurological disorders: what we know so far? Int J Biol Sci. 2024;20(4):1332-1355.
- 2.Rahman I, Biswas SK, Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol. 2006;72(11):1439-1452.
- 3.Mecocci P, Polidori MC. Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease. Biochim Biophys Acta. 2012;1822(5):631-638.
- 4.Dajas F. Life or death: neuroprotective and anticancer effects of flavonoids. J Ethnopharmacol. 2012;143(2):373-380.